Drug R&D Public Funding – The Next Level Of Price Transparency Policies? French lawmakers are setting the scene for a showdown with manufacturers defending their drug prices with R&D investment figures. Read More »
Three Reasons Why Value Definition Is The Ultimate Challenge for Pharma I have learned the hard way that defining the value of a pharmaceutical innovation is not as easy as “Bob’s your uncle”. Read More »
Three Reasons not to Use R&D Costs to Justify Drug Prices As pharma industry leaders continue to feel a pressuring demand from all parts to justify the price of their innovative products, there is one trap everyone seems to be happily falling into – the cost of Research and Development. Read More »